Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-15-013868
Filing Date
2015-09-30
Accepted
2015-09-30 14:47:05
Documents
1
Effectiveness Date
2015-09-30

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-15-013868.paper CERTNAS 294
  Scanned paper document scanned.pdf   37080
  Complete submission text file 9999999997-15-013868.txt   1333
Mailing Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERTNAS | Act: 34 | File No.: 001-37568 | Film No.: 15008276
SIC: 2834 Pharmaceutical Preparations